Eric Chatelain
Drugs for Neglected Diseases Initiative(CH)
Publications by Year
Research Areas
Trypanosoma species research and implications, Research on Leishmaniasis Studies, Synthesis and Biological Evaluation, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies
Most-Cited Works
- → p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells(1999)698 cited
- → In vitro and in vivo experimental models for drug screening and development for Chagas disease(2010)341 cited
- → Chagas Disease Drug Discovery: Toward a New Era(2014)309 cited
- → Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?(2012)284 cited
- → Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development(2014)205 cited
- → Photostabilization of Butyl methoxydibenzoylmethane (Avobenzone) and Ethylhexyl methoxycinnamate by Bis-ethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S), a New UV Broadband Filter¶(2001)201 cited
- → Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols(1993)174 cited
- → Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds(2010)167 cited
- → Skin Penetration and Sun Protection Factor of Five UV Filters: Effect of the Vehicle(2003)149 cited
- → Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging(2015)143 cited